ANTI-PROLIFERATION EFFECT OF ORIDONIN ONHL-60 CELLS AND ITS MECHANISM

被引:3
作者
Jiajun LiuXinyao WuHuiling LuXianglin PanJun Pengand Renwei Huang Laboratory of Forensic and Biological ScienceMedical College ofSun YatSen UniversityGuangzhou Central Department of Hematology and OncologyMedical College of Shandong UniversityJinan Department of Hematology and Oncologythe Third Affiliated Hospital of Sun YatSen UniversityGuangzhou [1 ,3 ,1 ,1 ,2 ,2 ,3 ,1 ,5100802 ,2500123 ,510630 ]
机构
关键词
oridonin; leukemia; telomerase; apoptosis;
D O I
暂无
中图分类号
R733.7 [白血病];
学科分类号
100214 ;
摘要
ObjectiveTo investigate the anti-proliferation effect of oridonin on leukemic HL-60 cells and its mechanism. Methods HL-60 cells invitroin culture medium were given different concentrations of oridonin. The inhibitory rate of cells were measured by microculture tetrazolium (MTT) assay, cell apoptotic rate was detected by flow cytometry (FCM),morphology of cell apoptosis was observed by hoechst 33258 fluorescence staining, and the activity of telomerase was det-ected using telomere repeat amplification protocol (TRAP) PCR-ELISA before and after apoptosis occurred. Results Oridonin could decrease telomerase activity, inhibit growth of HL-60 cells, and cause apoptosis significantly. The suppression was both in time- and dose-dependent manner. Marked morphological changes of cell apoptosis including condensation of chromatin and nuclear fragmentation were observed clearly by hoechst 33258 fluorescence staining especi-ally after cells were treated 48-60 hours by oridonin. Conclusions Oridonin has apparent anti-proliferation and apoptotic effects on HL-60 cells invitro, decreasing telomerase activity of HL-60 cells may be one of its most important mechanisms. These results will provide strong laboratory evidence of oridonin for clinical treatment of acute leukemia.
引用
收藏
页码:134 / 137
页数:4
相关论文
共 2 条
[1]   冬凌草甲素逆转多药耐药细胞系K562/A02耐药性的研究 [J].
郭娟娟 ;
邹俊晖 ;
潘祥林 ;
冯长伟 .
上海医学, 2002, (01) :43-45
[2]   Oridonin induces growth inhibition and apoptosis of a variety of human cancer cells [J].
Ikezoe, T ;
Chen, SS ;
Tong, XJ ;
Heber, D ;
Taguchi, H ;
Koeffler, HP .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2003, 23 (04) :1187-1193